BOLTON SECURITIES CORPORATION’s Tonix Pharmaceuticals TNXP Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.79K	Buy	+100	New	+$2.03K	﹤0.01%	1744

Other funds holding TNXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $47B AUM 34.17% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's TNXP Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Tonix Pharmaceuticals (TNXP) in Q1 2025: 100 shares worth $1.79K. The stake represents ﹤0.01% of the portfolio and ranks #1744 among its holdings.

27 funds tracked by Wall St. Rank hold TNXP as of Q1 2025.

BOLTON SECURITIES CORPORATION held 100 shares of Tonix Pharmaceuticals worth $1.79K as of Q1 2025.
Tonix Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Tonix Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1744 holding.
27 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.